Home
NSE: BLISSGVS
ISIN
NSE: BLISSGVS
Share Price
1M
1Y
3Y
5Y
Date | Price (₹) |
---|---|
04 Feb 2025 | 139.9 |
03 Feb 2025 | 144.45 |
01 Feb 2025 | 149.8 |
31 Jan 2025 | 149.35 |
30 Jan 2025 | 156.55 |
29 Jan 2025 | 146.65 |
28 Jan 2025 | 148.4 |
27 Jan 2025 | 150.8 |
24 Jan 2025 | 161.95 |
23 Jan 2025 | 164.6 |
Company Name | ISIN Code |
---|---|
Cipla Ltd | INE059A01026 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Mankind Pharma Ltd | INE634S01028 |
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Bliss GVS Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Net Profit of Bliss GVS Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 24 October 2024. Po
Read more
18 Oct 24
Net profit of Bliss GVS Pharma declined 42.66% to Rs 24.26 crore in the quarter ended September 2024
Read more
25 Oct 24
Bliss GVS Pharma has allotted 157,550 equity shares under ESOP on 04 October 2024. With this allotme
Read more
04 Oct 24
Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 28 January 2025. Po
Read more
22 Jan 25